8RQN image
Deposition Date 2024-01-18
Release Date 2024-09-11
Last Version Date 2024-11-20
Entry Detail
PDB ID:
8RQN
Title:
Human thyroid hormone receptor beta ligand binding domain in complex with beta-selective agonist ALG-055009
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.88 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Thyroid hormone receptor beta
Gene (Uniprot):THRB
Chain IDs:A
Chain Length:281
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CAF A CYS modified residue
Ligand Molecules
Primary Citation
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-beta ) Agonist for the Treatment of MASH.
J.Med.Chem. 67 14840 14851 (2024)
PMID: 39221768 DOI: 10.1021/acs.jmedchem.4c01029

Abstact

Agonists of thyroid hormone receptor β (THR-β) decreased LDL cholesterol (LDL-C) and triglyceride (TG) levels in human clinical trials for patients with dyslipidemia. The authors present the highly potent and selective compound ALG-055009 (14) as a potential best in class THR-β agonist. The high metabolic stability and good permeability translated well in vivo to afford a long in vivo half-life pharmacokinetic profile with limited liability for DDI, and it overcomes certain drawbacks seen in recent clinical candidates.

Legend

Protein

Chemical

Disease

Primary Citation of related structures